Chemical Stock Jumps 4% After Promoter Increases Stake by 3.65% in the Company

Synopsis: The shares of Small-Cap stock rose by 4% after its promoter, Cadamba Solutions, acquired 10,00,000 equity shares via a preferential allotment at ₹1,610 per share, totalling ₹161 crore.

The shares of the Small-Cap stock, which specialises in manufacturing high-quality Bromine-based compounds, Grignard Reagents, and Inorganic Lithium Salts, have been in the spotlight following a 4 percent rise upon the promoter increasing its stake in the company.

With a market capitalisation of Rs. 4,036.40 crores on the day’s trade, the shares of Neogen Chemicals Ltd rose upto 4.3 percent, reaching a high of Rs. 1559.00 per share compared to its previous closing price of Rs. 1494.65 per share. 

What happened

Neogen Chemicals Ltd, engaged in manufacturing high-quality Bromine-based compounds, Grignard Reagents, and Inorganic Lithium Salts, is in focus after the promoter increasing stake in the company.

Cadamba Solutions Private Limited has disclosed that it acquired 10,00,000 equity shares of Neogen Chemicals Limited through a preferential allotment on April 18, 2026. The shares were issued at Rs. 1,610 per share, totalling approximately Rs. 161 crore, and represent about 3.79% of the pre-allotment equity capital and 3.65% post-allotment capital of the company.

The disclosure was filed with both BSE and NSE, confirming that the acquirer belongs to the promoter group and has no persons acting in concert for this transaction. The company’s paid-up equity capital increased from Rs. 26.38 crore to Rs. 27.38 crore as a result of the allotment.

Financials & Others

The company’s revenue rose by 9.23 percent from Rs. 201.43 crore in December 2024 to Rs. 220.02 crore in December 2025. Meanwhile, the Net profit declined from  Rs. 10.01 crore to  Rs. 3.69 crore during the same period.

The company’s top-line growth was driven by higher volumes in both organic and inorganic chemicals, supported by steady demand. Despite capacity constraints at Dahej, the company maintained strong operating volumes through toll manufacturing arrangements, ensuring business continuity and stable production levels.

It has delivered strong long-term growth with a median sales increase of 23.8% over the last 10 years, showing steady expansion. However, profitability efficiency is moderate, with ROCE at 8.82% and ROE at 5.59%, indicating that returns generated on capital and equity remain relatively low.

In Q3 FY26, the revenue from Organic Chemicals increased from Rs. 177 crores in Q3 FY25 to Rs. 187 crores, reflecting a growth of 6 percent. Meanwhile, the revenue from Inorganic Chemicals rose from Rs. 24 crores in Q3 FY25 to Rs. 33 crores in Q3 FY26, marking a significant increase of 35 percent.

Neogen Chemicals Ltd, established in 1989 and based in Maharashtra, India, is a leading manufacturer specialising in bromine-based compounds, lithium-based compounds, and Grignard reagents. They serve the pharmaceutical, agrochemical, and engineering industries, with expansion into electrolytes for lithium-ion batteries and a strong focus on custom synthesis. 

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Chemical Stock Jumps 4% After Promoter Increases Stake by 3.65% in the Company appeared first on Trade Brains.